Browsing Tag

#FGF21

Akero Therapeutics Presents Analysis at the 2022 International Liver Congress Showing…

Eli Pacheco Jun 27, 2022 0

SOUTH SAN FRANCISCO, Calif., June 27, 2022 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with…

Health

A single hormone directs body’s responses to low-protein diet: Mice live longer…

Eli Pacheco May 14, 2022 0

A single hormone appears to coordinate the lifespan extension produced by a low-protein diet. A new study from Pennington Biomedical Research Center, published in the journal Nature…

Health

Akero Presents New Analysis of Phase 2a BALANCED Study Data Showing Additional…

Eli Pacheco Nov 12, 2021 0

Most EFX-treated patients with end-of-treatment biopsies showed improvements in features of steatohepatitis (35 of 40; 87%) and/or fibrosis (32 of 40; 80%), after only 16 weeks…

Health

Study Published in Nature Medicine Shows Investigational NASH Drug Reduced Liver Fat…

Eli Pacheco Jul 8, 2021 0

SOUTH SAN FRANCISCO, Calif., July 08, 2021 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a cardio-metabolic biotechnology company developing transformational treatments for…

Health

Akero Therapeutics Presents at the American Diabetes Association’s 81st Scientific…

Eli Pacheco Jun 27, 2021 0

SOUTH SAN FRANCISCO, Calif., June 25, 2021 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a cardio-metabolic biotechnology company developing transformational treatments for…